Synthetic Biologics Reports Expected Q1 Results and Kohl's Corporation Reports Disappointing Earnings
Synthetic Biologics Inc. (NYSE: SYN) reported its first-quarter results revealing a loss of $3.84 million, or 7 cents a share. This was in line with the Capital IQ Consensus Estimate of a loss of 7 cents a share. The company did not report any revenue but plans to start a 28-day bridging toxicology study in June for its SYN-004 oral enzyme for the prevention of C. difficile infections. Synthetic Biologics also expects to start Phase Ia and Ib clinical trials in the second half of 2014, with preliminary topline data expected by the end of the year. The company further plans to begin a Phase II efficacy study in the first half of 2015.
Synthetics Biologics, Inc., a biotechnology company, focuses on development of novel anti-infective biologics and drug candidates targeting specific pathogens that cause serious infections and other diseases.
Get more information on Synthetic Biologics Inc. and free access to the in depth equity report at: www.TrendingWallStreet.com/stockquote/SYN
TrendingWallStreet.com wants to help everyday people gain awareness about some of the hottest penny stocks trading in the stock market today. TrendingWallStreet.com releases momentum alerts on companies that you may have never heard about or thought about looking at. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get full access to our free stock reports.
Kohl's Corp. (NYSE: KSS) reported earnings and revenue that came in lower than analysts expected over its first quarter. Kohls reported that it earned 60 cents a share in its first quarter, coming in 2 cents below estimates according to analysts surveyed by Thomson Reuters. The company's revenue of $4.07 billion fell 3.1% year over year and missed forecasts of $4.22 billion. Comparable-store sales dropped 3.4% compared to analysts' forecasts of 0.2% growth.
Kohl's Corporation operates department stores in the United States. It offers exclusive and national brand apparel, footwear, accessories, beauty, and soft home products to children, men, and women customers. As of February 1, 2014, it operated 1,158 family-oriented department stores and a Website, Kohls.com.
Get more information on Kohl's Corp. and free access to the in depth equity report at: www.TrendingWallStreet.com/stockquote/KSS
Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.
Tags: